JP2004505932A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004505932A5 JP2004505932A5 JP2002517105A JP2002517105A JP2004505932A5 JP 2004505932 A5 JP2004505932 A5 JP 2004505932A5 JP 2002517105 A JP2002517105 A JP 2002517105A JP 2002517105 A JP2002517105 A JP 2002517105A JP 2004505932 A5 JP2004505932 A5 JP 2004505932A5
- Authority
- JP
- Japan
- Prior art keywords
- product
- lactoferrin
- labeled
- tumor
- product according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010063045 Lactoferrin Proteins 0.000 claims 18
- 102100032241 Lactotransferrin Human genes 0.000 claims 18
- 229940078795 lactoferrin Drugs 0.000 claims 17
- 235000021242 lactoferrin Nutrition 0.000 claims 17
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims 16
- 238000000034 method Methods 0.000 claims 10
- 206010028980 Neoplasm Diseases 0.000 claims 8
- 239000003638 chemical reducing agent Substances 0.000 claims 7
- 238000003384 imaging method Methods 0.000 claims 4
- 208000003174 Brain Neoplasms Diseases 0.000 claims 3
- 239000002872 contrast media Substances 0.000 claims 3
- 238000003745 diagnosis Methods 0.000 claims 3
- 239000007951 isotonicity adjuster Substances 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical group OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- 102000014914 Carrier Proteins Human genes 0.000 claims 2
- 108010078791 Carrier Proteins Proteins 0.000 claims 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000013011 aqueous formulation Substances 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 2
- 239000002184 metal Substances 0.000 claims 2
- 229910052751 metal Inorganic materials 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 102000007474 Multiprotein Complexes Human genes 0.000 claims 1
- 108010085220 Multiprotein Complexes Proteins 0.000 claims 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 239000003125 aqueous solvent Substances 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229960005219 gentisic acid Drugs 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- -1 tin (II) compound Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0019412.6A GB0019412D0 (en) | 2000-08-08 | 2000-08-08 | New imaging agent |
| PCT/GB2001/003531 WO2002011772A2 (en) | 2000-08-08 | 2001-08-07 | Radiolabelled metal transport proteins as imaging agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004505932A JP2004505932A (ja) | 2004-02-26 |
| JP2004505932A5 true JP2004505932A5 (enExample) | 2005-03-03 |
Family
ID=9897174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002517105A Pending JP2004505932A (ja) | 2000-08-08 | 2001-08-07 | 造影剤としての放射性標識金属輸送タンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7160536B2 (enExample) |
| EP (1) | EP1307240A2 (enExample) |
| JP (1) | JP2004505932A (enExample) |
| AU (1) | AU2001278585A1 (enExample) |
| CA (1) | CA2418383A1 (enExample) |
| GB (1) | GB0019412D0 (enExample) |
| WO (1) | WO2002011772A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0019412D0 (en) * | 2000-08-08 | 2000-09-27 | Univ York | New imaging agent |
| US20060083684A1 (en) * | 2002-02-12 | 2006-04-20 | Walton Paul H | Method of radio-labelling biomolecules |
| US7183381B2 (en) | 2004-10-26 | 2007-02-27 | Agennix, Inc. | Composition of lactoferrin related peptides and uses thereof |
| DE102005051366A1 (de) * | 2005-10-25 | 2007-04-26 | Degussa Gmbh | Drug Delivery Systeme |
| CA2627459C (en) * | 2005-10-25 | 2011-08-09 | Evonik Degussa Gmbh | Preparations containing hyperbranched polymers |
| EP1982698A1 (de) * | 2007-04-18 | 2008-10-22 | Evonik Degussa GmbH | Präparate zur gesteuerten Freisetzung von bioaktiven Naturstoffen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4057617A (en) * | 1975-05-15 | 1977-11-08 | Abramovici J | Method of labeling proteins with technetium |
| JPH08505119A (ja) | 1992-07-06 | 1996-06-04 | バイオミラ、インコーポレーテッド | 接合目的のためのタンパク質の光活性化 |
| GB0019412D0 (en) * | 2000-08-08 | 2000-09-27 | Univ York | New imaging agent |
-
2000
- 2000-08-08 GB GBGB0019412.6A patent/GB0019412D0/en not_active Ceased
-
2001
- 2001-08-07 CA CA002418383A patent/CA2418383A1/en not_active Abandoned
- 2001-08-07 US US10/344,079 patent/US7160536B2/en not_active Expired - Fee Related
- 2001-08-07 EP EP01956661A patent/EP1307240A2/en not_active Withdrawn
- 2001-08-07 WO PCT/GB2001/003531 patent/WO2002011772A2/en not_active Ceased
- 2001-08-07 AU AU2001278585A patent/AU2001278585A1/en not_active Abandoned
- 2001-08-07 JP JP2002517105A patent/JP2004505932A/ja active Pending
-
2006
- 2006-10-05 US US11/543,671 patent/US20070036720A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3853354B2 (ja) | 放射性標識ペプチドおよびタンパク質の自己放射線分解を防止する安定剤 | |
| Gaynor et al. | The prevalence of metal-based drugs as therapeutic or diagnostic agents: beyond platinum | |
| JP7242538B2 (ja) | 放射線治療及び画像診断のための製剤 | |
| CA1173828A (en) | Diagnostic composition for radiologic imaging of neoplasms in the body and method of preparation | |
| ES2736134T3 (es) | Derivado peptídico de tiourea, compuesto marcado con radioisótopos que contiene el mismo y composición farmacéutica que contiene el mismo como ingrediente activo para tratar o diagnosticar el cáncer de próstata | |
| RU2594167C2 (ru) | Композиции пептидных радиоактивных индикаторов | |
| ES2308778T3 (es) | Composiciones de peptidos radiomarcados para dirigir a un sitio especifico. | |
| KR20050119205A (ko) | 갈륨-68을 얻는 방법, 갈륨-68의 용도 및 상기 방법의수행을 위한 장치 | |
| JPH10500411A (ja) | ソマトスタチン結合性ペプチド−金属キレートコンジュゲート | |
| EP2658581B1 (en) | A conjugate of human albumin and 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid useful for the localization of radionuclides for diagnostic and therapeutic purposes | |
| JP3558169B2 (ja) | 新規化合物及びその製造方法並びに診断用薬剤 | |
| KR0175305B1 (ko) | 방사능의약품 조성물의 제조방법 | |
| JP2000515847A (ja) | ペプチド放射性医薬品用途 | |
| CN117159753A (zh) | 放射性标记的伊文思蓝衍生物药物的制备方法及用途 | |
| CN1771058A (zh) | 制备放射性标记的镓络合物的微波方法 | |
| JP2004505932A5 (enExample) | ||
| Mukiza et al. | A review on technetium and rhenium based radiopharmaceuticals for diagnostic imaging and therapeutic nuclear medicine | |
| Zhao et al. | 68Ga-labeled dimeric and trimeric cyclic RGD peptides as potential PET radiotracers for imaging gliomas | |
| CA1105815A (en) | Red blood cell labelling kit | |
| Ferro-Flores et al. | Radiolabeled protein-inhibitor peptides with rapid clinical translation towards imaging and therapy | |
| RU2568888C1 (ru) | СПОСОБ И СОСТАВ ДЛЯ ПОЛУЧЕНИЯ РЕАГЕНТА ДЛЯ РАДИОНУКЛИДНОЙ ДИАГНОСТИКИ НА ОСНОВЕ МЕЧЕННОЙ ТЕХНЕЦИЕМ-99m 5-ТИО-D-ГЛЮКОЗЫ | |
| CN109316609A (zh) | 选择患者的方法 | |
| ES2223559T3 (es) | Complejos de metales de transicion del grupo (vii) con ligandos aminopolicarboxilato multidentados y kit para producirlos. | |
| KR20070106731A (ko) | 방사성표지된 갈륨 복합체, 그의 합성방법 및 악성종양에서 egfr 발현의 pet 영상화를 위한 그의 용도 | |
| WO2023202730A2 (zh) | 放射性伊文思蓝衍生物药物水溶液及其制备方法和用途 |